Preoperative neutrophil-to-platelet ratio as a potential prognostic factor for gastric cancer with positive peritoneal lavage cytology in the absence of other non-curative factors: a multi-institutional dataset analysis

[1]  M. Kanda,et al.  Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer , 2020, Molecular Cancer.

[2]  E. Hwang,et al.  Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy , 2020, Scientific Reports.

[3]  M. Kanda,et al.  Survival times are similar among patients with peritoneal, hematogenous, and nodal recurrences after curative resections for gastric cancer , 2020, Cancer medicine.

[4]  Japanese Gastric Cancer Association.  Japanese gastric cancer treatment guidelines 2018 (5th edition) , 2020, Gastric Cancer.

[5]  Zhen Wang,et al.  Issues on peritoneal metastasis of gastric cancer: an update , 2019, World Journal of Surgical Oncology.

[6]  A. Abe,et al.  Correlation between Prognostic Nutritional Index and occlusal status in Gastric Cancer. , 2019, Oral diseases.

[7]  Hyo Song Kim,et al.  Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer , 2019, Journal of Immunotherapy for Cancer.

[8]  M. Kanda.  Preoperative predictors of postoperative complications after gastric cancer resection , 2019, Surgery Today.

[9]  H. Katai,et al.  Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study , 2019, Annals of Surgical Oncology.

[10]  M. Kanda,et al.  Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study , 2019, Gastric Cancer.

[11]  M. Kanda,et al.  The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution Dataset , 2019, Digestive Surgery.

[12]  M. Kanda,et al.  The Controlling Nutritional Status Score Serves as a Predictor of Short- and Long-Term Outcomes for Patients with Stage 2 or 3 Gastric Cancer: Analysis of a Multi-institutional Data Set , 2018, Annals of Surgical Oncology.

[13]  Teruhiko Fukaya.  Japanese , 2018, Definitions.

[14]  M. Kanda,et al.  Significance of Preoperative Systemic Inflammation Score in Short-Term and Long-Term Outcomes of Patients with Pathological T2–4 Gastric Cancer After Radical Gastrectomy , 2018, World Journal of Surgery.

[15]  K. Ohta,et al.  Prognostic factors for cytology-positive gastric cancer , 2018, Surgery Today.

[16]  M. Kanda,et al.  Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer , 2016, Annals of surgery.

[17]  M. Kanda,et al.  Preoperative Albumin–Bilirubin Grade Predicts Recurrences After Radical Gastrectomy in Patients with pT2-4 Gastric Cancer , 2018, World Journal of Surgery.

[18]  M. Kanda,et al.  Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer , 2017, World journal of gastroenterology.

[19]  Hongtu Zheng,et al.  Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis , 2016, World Journal of Surgical Oncology.

[20]  A. Richardson,et al.  Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells. , 2012, Cancer discovery.

[21]  W. Ruf.  Tissue factor and cancer. , 2012, Thrombosis research.

[22]  T. Kubota,et al.  Significance of the Inflammation-Based Glasgow Prognostic Score for Short- and Long-Term Outcomes After Curative Resection of Gastric Cancer , 2012, Journal of Gastrointestinal Surgery.

[23]  D. Scadden,et al.  Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis , 2012, Proceedings of the National Academy of Sciences.

[24]  Y. Kodera,et al.  Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study , 2012, Gastric Cancer.

[25]  T. Kawano,et al.  Correlation Between the Pretherapeutic Neutrophil to Lymphocyte Ratio and the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Advanced Esophageal Cancer , 2012, World Journal of Surgery.

[26]  M. Chatterjee,et al.  Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli. , 2011, Blood.

[27]  Alyssa D Gregory,et al.  Tumor-associated neutrophils: new targets for cancer therapy. , 2011, Cancer research.

[28]  Japanese Gastric Cancer Association.  Japanese classification of gastric carcinoma: 3rd English edition , 2011, Gastric Cancer.

[29]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[30]  Y. Kodera,et al.  A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study). , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[31]  H. Salih,et al.  Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. , 2009, Cancer research.

[32]  D. McMillan.  Systemic inflammation, nutritional status and survival in patients with cancer , 2009, Current opinion in clinical nutrition and metabolic care.

[33]  M. Schuler,et al.  Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivo , 2005, Cell Death and Differentiation.

[34]  胃癌研究会.  Japanese classification of gastric carcinoma , 1995 .